Two CAR-T Cancer Immunotherapy Trials on Clinical Hold After Patient Death – P&T Community
Xconomy |
Two CAR-T Cancer Immunotherapy Trials on Clinical Hold After Patient Death
P&T Community The FDA has placed a clinical hold on two gene-edited allogeneic CAR T-cell (UCART) phase 1 studies being conducted by Cellectis after the report of a patient death. The studies are evaluating UCART123 immunotherapy in patients with acute myeloid … Patient Death Triggers FDA Hold For Cellectis’s “Off the Shelf” CAR-TXconomy Here’s Why Cellectis SA Fell as Much as 31.6% TodayMotley Fool After Patient Death, FDA Places Clinical Hold on Cellectis CAR-T Candidate UCART123Genetic Engineering & Biotechnology News |
Liberty Nation (registration) (blog) |
FDA Commissioner Announces Stem Cell Enforcement Shift, Plans to Develop Comprehensive Regenerative Medicine …
The National Law Review In a major public move that has been long-awaited by proponents of evidence-based stem cell science, FDA Commissioner Scott Gottlieb issued a lengthy statement on August 28, 2017 “on the FDA’s new policy steps and enforcement efforts to ensure proper … FDA Scrutinizing Stem Cell ClinicsFinancial Advisor Magazine (registration) Stem cell: Obama revives volatile debateIndependent Online FDA crackdown on unproven stem cell therapiesBioNews Liberty Nation (registration) (blog) –Guardian Liberty Voice –Medgadget (blog) all 21 news articles » |
|
Experts Laud FDA’s Stepped-Up Stem Cell Efforts
Bloomberg BNA The FDA’s new plans to crack down on “unscrupulous” stem cell clinics but also speed up new therapy development is welcome and necessary, experts said. Food and Drug Administration Commissioner Scott Gottlieb announced Aug. 28 his agency will … |
Washington University School of Medicine in St. Louis |
Zika Virus Targets and Kills Brain Cancer Stem Cells
UC San Diego Health “The Zika virus specifically targets neuroprogenitor cells in fetal and adult brains. Our research shows it also selectively targets and kills cancer stem cells, which tend to be resistant to standard treatments and a big reason why glioblastomas recur … Zika virus kills brain cancer stem cellsWashington University School of Medicine in St. Louis Zika kills brain cancer cells, may find use as therapy – The San …The San Diego Union-Tribune Zika virus can kill brain tumor cells, Washington University …STLtoday.com HuffPost –BBC News –Medical News Today –The Journal of Experimental Medicine – The Rockefeller University Press all 56 news articles » |
Financial Times |
Japan’s stem–cell race
Financial Times An audio version of the best of the Financial Times’s Big Reads — in-depth reporting from FT correspondents around the world. Listen to longform stories that explore and explain key themes in world news, science and business. Produced by Anna Dedhar. |